The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 13, 2017

Study Completion Date

June 13, 2017

Conditions
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Trial Locations (1)

10029

Susan and Leonard Feinstein Inflammatory Bowel Disease Center, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02423512 - The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness | Biotech Hunter | Biotech Hunter